Page last updated: 2024-08-21

hematoporphyrin and Carcinoma, Pancreatic Ductal

hematoporphyrin has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Callan, JF; Davidson, B; Farrell, S; Hadi, MM; Kubajewska, I; MacRobert, AJ; Masood, H; McHale, AP; Nesbitt, H; Ng, A; Nomikou, N; Patel, S; Sciscione, F; Thomas, K	1

Other Studies

1 other study(ies) available for hematoporphyrin and Carcinoma, Pancreatic Ductal

Article	Year
Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma. Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:8 Topics: Animals; Carcinoma, Pancreatic Ductal; Cathepsin B; Cell Line, Tumor; Hematoporphyrins; Mice; Nanotechnology; Pancreatic Neoplasms; Reactive Oxygen Species; Tissue Distribution; Ultrasonic Therapy	2023

Article

Year

Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma.

Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:8

Topics: Animals; Carcinoma, Pancreatic Ductal; Cathepsin B; Cell Line, Tumor; Hematoporphyrins; Mice; Nanotechnology; Pancreatic Neoplasms; Reactive Oxygen Species; Tissue Distribution; Ultrasonic Therapy

2023